Beyond prostate specific antigen: Markers for prostate cancer for the 21st centuryKADMON, D.The Journal of urology. 2000, Vol 163, Num 3, issn 0022-5347, p. 828Article

SURGICAL CONSIDERATIONS IN TREATMENT OF INTRADUETAL CARCINOMA OF THE PROSTATE.CATALONA WJ; KADMON D; MARTIN SA et al.1978; J. UROL.; USA; DA. 1978; VOL. 120; NO 2; PP. 259-261; BIBL. 19 REF.Article

Alpha-difluoromethyornithine enhancement of ¹⁴C-putrescine uptake by an androgen-dependent prostatic tumorHESTON, W. D. W; KADMON, D.The Journal of urology. 1986, Vol 136, Num 4, pp 944-948, issn 0022-5347Article

Percutaneous drainage of prostatic abscessesKADMON, D; LING, D; LEE, J. K. T et al.The Journal of urology. 1986, Vol 135, Num 6, pp 1259-1260, issn 0022-5347Conference Paper

Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancerSHALEV, M; KADMON, D; TEH, B. S et al.The Journal of urology. 2000, Vol 163, Num 6, pp 1747-1750, issn 0022-5347Article

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer : Results of a randomized, double-blind, placebo-controlled clinical trial. CommentaryANDRIOLE, G. L; GUESS, H. A; COOK, T. J et al.Urology (Ridgewood, NJ). 1998, Vol 52, Num 2, pp 195-202, issn 0090-4295Article

Elevated plasma chromogranin-a concentrations in a prostatic carcinimaKADMON, D; THOMPSON, T. C; LYNCH, G. R et al.The Journal of urology. 1991, Vol 146, Num 2, pp 358-361, issn 0022-5347Article

Unilocular retroperitoneal cyst of mesothelial origin presenting as a renal mass : A report of 2 casesSMITH, V. C; EDWARDS, R. A; JORGENSEN, J. L et al.Archives of pathology & laboratory medicine (1976). 2000, Vol 124, Num 5, pp 766-769, issn 0363-0153Article

Intracranial metastases as the first manifestation of prostate cancerSUTTON, M. A; WATKINS, H. L; GREEN, L. K et al.Urology (Ridgewood, NJ). 1996, Vol 48, Num 5, pp 789-793, issn 0090-4295Article

Mesenchymal-epithelial interactions and transforming growth factor-β expression during mouse prostate morphogenesisTIMME, T. L; TRUONG, L. D; MERZ, V. W et al.Endocrinology (Philadelphia). 1994, Vol 134, Num 3, pp 1039-1045, issn 0013-7227Article

Inhibition of mouse bladder tumor proliferation by murine interferon-γ and its synergism with interferon-βRATLIFF, T. L; KADMON, D; SHAPIRO, A et al.Cancer research (Baltimore). 1984, Vol 44, Num 10, pp 4377-4381, issn 0008-5472Article

Differential effect of α-difluoromethylornithine on the in vivo uptake of ¹⁴C-labeled polyamines and methylglyoxal bis(guanylhydrazone) by a rat prostate-derived tumor = Effet différentiel de l'alpha-difluorométhylornithine sur l'incorporation in vivo des polyamines marqués au C14 et de méthylglyoxal bis (guanyl-hydrazone) par une tumeur isolée de la prostate de ratHESTON, W. D. W; KADMON, D; COVEY, D. F et al.Cancer research (Baltimore). 1984, Vol 44, Num 3, pp 1034-1040, issn 0008-5472Article

Differential expression of nuclear retinoid receptors in normal and malignant prostatesLOTAN, Y; XU, X. C; SHALEV, M et al.Journal of clinical oncology. 2000, Vol 18, Num 1, pp 116-121, issn 0732-183XArticle

Pitfalls in interpreting prostate specific antigen velocity. CommentaryKADMON, D; WEINBERG, A. D; WILLIAMS, R. H et al.The Journal of urology. 1996, Vol 155, Num 5, pp 1655-1657, issn 0022-5347Article

Retroviral transduction of transforming growth factor-β1 induces pleiotropic benign prostatic growth abnormalities in mouse prostate reconstitutionsTIMME, T. L; YANG, G; ROGERS, E et al.Laboratory investigation. 1996, Vol 74, Num 4, pp 747-760, issn 0023-6837Article

Transitional cell carcinoma in a tuberculous kidney : case report and review of the literatureFEENEY, D; QUESADA, E. T; SIRBASKU, D. M et al.The Journal of urology. 1994, Vol 151, Num 4, pp 989-991, issn 0022-5347Article

Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostateTHOMPSON, T. C; TIMME, T. L; KADMON, D et al.Molecular carcinogenesis (Print). 1993, Vol 7, Num 3, pp 165-179, issn 0899-1987Article

Transgenic models for the study of prostate cancerTHOMPSON, T. C; TRUONG, L. D; TIMME, T. L et al.Cancer. 1993, Vol 71, Num 3, pp 1165-1171, issn 0008-543X, SUPConference Paper

Androgen sensitivity and gene expression in ras+myc-induced mouse prostate carcinomasTHOMPSON, T. C; EGAWA, S; KADMON, D et al.Journal of steroid biochemistry and molecular biology. 1992, Vol 43, Num 1-3, pp 79-85, issn 0960-0760Conference Paper

Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancerVAN DER LINDEN, R. R. M; HAAGMANS, B. L; MONGIAT-ARTUS, P et al.European urology. 2005, Vol 48, Num 1, pp 153-161, issn 0302-2838, 9 p.Article

Cytopathic effect of in situ gene therapy in prostate cancerAYALA, G; WHEELER, T. M; SHALEV, M et al.Human pathology. 2000, Vol 31, Num 7, pp 866-870, issn 0046-8177Article

Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate. Editorial commentISCHIA, R; HOBISCH, A; FISCHER-COLBRIE, R et al.The Journal of urology. 2000, Vol 163, Num 4, pp 1161-1165, issn 0022-5347Article

Treatment with finasteride following radical prostatectomy for prostate cancerANDRIOLE, G; LIEBER, M; RAMSEY, E et al.Urology (Ridgewood, NJ). 1995, Vol 45, Num 3, pp 491-497, issn 0090-4295Article

Tissue and cell-cell interactions in prostate cancer progressionTHOMPSON, T. C; TIMME, T. L; PARK, S. H et al.Cancer. 1995, Vol 75, Num 7, pp 1885-1891, issn 0008-543X, SUPConference Paper

Association of transforming growth factor-β₁ with prostate cancer : an immunohistochemical studyTRUONG, L. D; KADMON, D; MCCUNE, B. K et al.Human pathology. 1993, Vol 24, Num 1, pp 4-9, issn 0046-8177Article